Yamamoto, T.; Mukai, Y.; Wada, F.; Terada, C.; Kayaba, Y.; Oh, K.; Yamayoshi, A.; Obika, S.; Harada–Shiba, M.
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides. Pharmaceutics 2021, 13, 817.
https://doi.org/10.3390/pharmaceutics13060817
AMA Style
Yamamoto T, Mukai Y, Wada F, Terada C, Kayaba Y, Oh K, Yamayoshi A, Obika S, Harada–Shiba M.
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides. Pharmaceutics. 2021; 13(6):817.
https://doi.org/10.3390/pharmaceutics13060817
Chicago/Turabian Style
Yamamoto, Tsuyoshi, Yahiro Mukai, Fumito Wada, Chisato Terada, Yukina Kayaba, Kaho Oh, Asako Yamayoshi, Satoshi Obika, and Mariko Harada–Shiba.
2021. "Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides" Pharmaceutics 13, no. 6: 817.
https://doi.org/10.3390/pharmaceutics13060817
APA Style
Yamamoto, T., Mukai, Y., Wada, F., Terada, C., Kayaba, Y., Oh, K., Yamayoshi, A., Obika, S., & Harada–Shiba, M.
(2021). Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides. Pharmaceutics, 13(6), 817.
https://doi.org/10.3390/pharmaceutics13060817